Advertisement
Organisation › Details
Orna Therapeutics (US)
Orna Therapeutics is a biotechnology company dedicated to designing and delivering a new class of fully engineered circular RNA (oRNA) therapeutics with the potential to change the way we treat disease. Orna’s proprietary platform combines novel technology to create oRNAs that drive protein expression with validated and unique delivery solutions. oRNA has many advantages over traditional mRNA approaches, including simplified production, improved formulatability, and superior protein expression – making it a highly disruptive, new class of RNA therapeutics with vast potential to change patient’s lives. *
Start | 2019-01-01 established (s-off) | |
Predecessor | MIT (Massachusetts Institute of Technology) | |
Industry | circular RNA therapeutic, synthetic (fully engineered) (oRNA) | |
Industry 2 | RNA technology | |
Region | Cambridge, MA | |
Country | United States (USA) | |
Street | 620 Memorial Drive 2nd Floor | |
City | 02139 Cambridge, MA | |
Address record changed: 2024-01-05 | ||
Basic data | Employees | n. a. |
* Document for »About Section«: Orna Therapeutics. (2/24/21). "Press Release: Orna Therapeutics Launches with over $100M Raised to Develop a New Class of Fully Engineered Circular RNA Therapies". Cambridge, MA. | ||
Record changed: 2024-01-20 |
Advertisement
More documents for Orna Therapeutics (US)
To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to info@iito.de and simply fill the subject line with the word »LSE Newsletter«
Find more infos about advertising at [iito] web portals in our media flyer [iito] in a Nutshell [PDF file]
Advertisement
» top